# OnCo record vivesto (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/vivesto/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "vivesto" ;
  schema:name "Vivesto"@en ;
  schema:alternateName "Vivesto AB"@en ;
  schema:description "Vivesto is a Swedish company developing cancer medicines, listed in Stockholm. Its human medicine Cantrixil is being developed for blood cancer and has orphan drug status in the United States for acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/companies/vivesto/>, <https://www.vivesto.com/en/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.vivesto.com/en/>, <https://www.vivesto.com/en/vivesto-receives-orphan-drug-designation-in-the-u-s-for-cantrixil-in-aml/>, <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1170226> ;
  schema:addressCountry "SE" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/cantrixil/> .